[HTML][HTML] Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies
P Muthukutty, J MacDonald, SY Yoo - Vaccines, 2024 - mdpi.com
Emerging viral diseases, including seasonal illnesses and pandemics, pose significant
global public health risks. Respiratory viruses, particularly coronaviruses and influenza …
global public health risks. Respiratory viruses, particularly coronaviruses and influenza …
[HTML][HTML] Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19
EE Nakayama, T Shioda - Pathogens, 2024 - mdpi.com
Antibody-dependent enhancement (ADE) is a phenomenon in which antibodies enhance
subsequent viral infections rather than preventing them. Sub-optimal levels of neutralizing …
subsequent viral infections rather than preventing them. Sub-optimal levels of neutralizing …
Humoral and cellular immune response to AZD1222/Covishield and BV152/Covaxin COVID-19 vaccines among adults in India
AS Tripathy, D Singh, D Trimbake, S Salwe… - Human Vaccines & …, 2024 - Taylor & Francis
Several COVID-19 vaccines were developed using different approaches to prevent both
symptomatic COVID-19 cases and fatalities. The adults were vaccinated with two doses of …
symptomatic COVID-19 cases and fatalities. The adults were vaccinated with two doses of …
Antibody response to non-mRNA SARS-CoV-2 vaccine in kidney transplant recipients
D Bajpai, S Bose, N Saxena, B Kulkarni, K Kumar… - Vaccine, 2024 - Elsevier
Abstract Background Kidney transplant recipients (KTRs) show poor antibody response to
the SARS-CoV-2 vaccine. There is limited data on immune response to non-mRNA vaccines …
the SARS-CoV-2 vaccine. There is limited data on immune response to non-mRNA vaccines …